{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:48:13Z","timestamp":1792673293143,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T00:00:00Z","timestamp":1519344000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1038\/s41375-018-0069-1","type":"journal-article","created":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T10:06:40Z","timestamp":1519380400000},"page":"1349-1357","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Transcriptomic landscape of acute promyelocytic leukemia reveals aberrant surface expression of the platelet aggregation agonist Podoplanin"],"prefix":"10.1038","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9095-0066","authenticated-orcid":false,"given":"Vincent-Philippe","family":"Lavall\u00e9e","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalila","family":"Chagraoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"MacRae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Marquis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Bonnefoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Krosl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Lemieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Marinier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9716-5909","authenticated-orcid":false,"given":"Caroline","family":"Pabst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges-\u00c9tienne","family":"Rivard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9e","family":"H\u00e9bert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Sauvageau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,23]]},"reference":[{"key":"69_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1300874","volume":"369","author":"F Lo-Coco","year":"2013","unstructured":"Lo-Coco F, Avvisati G, Vignetti M, Thiede C, Orlando S, Iacobelli S, et al. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. New Engl J Med. 2013;369:111\u201321.","journal-title":"New Engl J Med"},{"key":"69_CR2","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1182\/blood-2011-04-346437","volume":"118","author":"JH Park","year":"2011","unstructured":"Park JH, Qiao B, Panageas KS, Schymura MJ, Jurcic JG, Rosenblat TL, et al. Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid. Blood. 2011;118:1248\u201354.","journal-title":"Blood"},{"key":"69_CR3","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/leu.2011.78","volume":"25","author":"S Lehmann","year":"2011","unstructured":"Lehmann S, Ravn A, Carlsson L, Antunovic P, Deneberg S, M\u00f6llg\u00e5rd L, et al. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry. Leukemia. 2011;25:1128\u201334.","journal-title":"Leukemia"},{"key":"69_CR4","doi-asserted-by":"publisher","first-page":"5650","DOI":"10.1182\/blood-2010-06-288613","volume":"116","author":"MS Tallman","year":"2010","unstructured":"Tallman MS, Kim HT, Montesinos P, Appelbaum FR, de la Serna J, Bennett JM, et al. Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group. Blood. 2010;116:5650\u20139.","journal-title":"Blood"},{"key":"69_CR5","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1200\/JCO.1992.10.9.1413","volume":"10","author":"A Rovelli","year":"1992","unstructured":"Rovelli A, Biondi A, Rajnoldi CA, Conter V, Giudici G, Jankovic M, et al. Microgranular variant of acute promyelocytic leukemia in children. J Clin Oncol. 1992;10:1413\u20138.","journal-title":"J Clin Oncol"},{"key":"69_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/MOH.0000000000000221","volume":"23","author":"S Mantha","year":"2016","unstructured":"Mantha S, Tallman M, Soff GA. What\u2019s new in the pathogenesis of the coagulopathy in acute promyelocytic leukemia?\u2019. Curr Opin Hematol. 2016;23:121\u20136.","journal-title":"Curr Opin Hematol"},{"key":"69_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.beha.2014.04.005","volume":"27","author":"HC Kwaan","year":"2014","unstructured":"Kwaan HC, Cull EH. The coagulopathy in acute promyelocytic leukaemia\u2014What have we learned in the past twenty years. Best Pract Res Clin Haematol. 2014;27:11\u20138.","journal-title":"Best Pract Res Clin Haematol"},{"key":"69_CR8","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1182\/blood.V84.9.3001.3001","volume":"84","author":"T Koyama","year":"1994","unstructured":"Koyama T, Hirosawa S, Kawamata N, Tohda S, Aoki N. All-trans retinoic acid upregulates thrombomodulin and downregulates tissue-factor expression in acute promyelocytic leukemia cells: distinct expression of thrombomodulin and tissue factor in human leukemic cells. Blood. 1994;84:3001\u20139.","journal-title":"Blood"},{"key":"69_CR9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1182\/blood.V92.1.143.413k18_143_151","volume":"92","author":"A Falanga","year":"1998","unstructured":"Falanga A, Consonni R, Marchetti M, Locatelli G. Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cells. Blood. 1998;92:143\u201351.","journal-title":"Blood"},{"key":"69_CR10","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1056\/NEJM199904013401303","volume":"340","author":"JS Menell","year":"1999","unstructured":"Menell JS, Cesarman GM, Jacovina AT, McLaughlin M, Lev EA, Hajjar KA. Annexin II and bleeding in acute promyelocytic leukemia. New Engl J Med. 1999;340:994\u20131004.","journal-title":"New Engl J Med"},{"key":"69_CR11","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.leukres.2010.11.008","volume":"35","author":"Y Liu","year":"2011","unstructured":"Liu Y, Wang Z, Jiang M, Dai L, Zhang W, Wu D, et al. The expression of annexin II and its role in the fibrinolytic activity in acute promyelocytic leukemia. Leuk Res. 2011;35:879\u201384.","journal-title":"Leuk Res"},{"key":"69_CR12","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/j.1365-2141.1989.tb06311.x","volume":"71","author":"B Bennett","year":"1989","unstructured":"Bennett B, Booth NA, Croll A. The bleeding disorder in acute promyelocytic leukaemia: fibrinolysis due to u\u2010PA rather than defibrination. Br J Haematol. 1989;71:511\u20137.","journal-title":"Br J Haematol"},{"key":"69_CR13","first-page":"2","volume":"7","author":"H Dombret","year":"1993","unstructured":"Dombret H, Scrobohaci M, Ghorra P, Zini J, Daniel M, Castaigne S, et al. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retnoic acid treatment. Leukemia. 1993;7:2\u20139.","journal-title":"Leukemia"},{"key":"69_CR14","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1182\/blood-2016-10-747170","volume":"129","author":"S Mantha","year":"2017","unstructured":"Mantha S, Goldman DA, Devlin SM, Lee J-WW, Zannino D, Collins M, et al. Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era. Blood. 2017;129:1763\u20137.","journal-title":"Blood"},{"key":"69_CR15","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1038\/leu.2016.69","volume":"30","author":"V Madan","year":"2016","unstructured":"Madan V, Shyamsunder P, Han L, Mayakonda A, Nagata Y, Sundaresan J, et al. Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia. Leukemia. 2016;30:1672\u201381.","journal-title":"Leukemia"},{"key":"69_CR16","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","volume":"368","author":"Network TCGAR.","year":"2013","unstructured":"Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. New Engl J Med. 2013;368:2059\u201374.","journal-title":"New Engl J Med"},{"key":"69_CR17","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1038\/ng.3371","volume":"47","author":"VP Lavallee","year":"2015","unstructured":"Lavallee V-P, Baccelli I, Krosl J, Wilhelm B, Barabe F, Gendron P, et al. The transcriptomic landscape and directed chemical interrogation of MLL-rearranged acute myeloid leukemias. Nat Genet. 2015;47:1030\u20137.","journal-title":"Nat Genet"},{"key":"69_CR18","doi-asserted-by":"publisher","first-page":"17017","DOI":"10.1073\/pnas.1011278107","volume":"107","author":"JYY Liu","year":"2010","unstructured":"Liu J-YY, Li N, Yang J, Li N, Qiu H, Ai D, et al. Metabolic profiling of murine plasma reveals an unexpected biomarker in rofecoxib-mediated cardiovascular events. Proc Natl Acad Sci USA. 2010;107:17017\u201322.","journal-title":"Proc Natl Acad Sci USA"},{"key":"69_CR19","unstructured":"Kroll MH, Biswas B, Budd JR, Durham P, Gorman RT, Gwise TE et al. Assessment of the diagnostic accuracy of laboratory tests using receiver operating characteristic curves; approved guideline-second edition. Clinical and Laboratory Standards Institute Document. 2011;31:1\u201345."},{"key":"69_CR20","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.leukres.2010.01.001","volume":"34","author":"A Beitinjaneh","year":"2010","unstructured":"Beitinjaneh A, Jang S, Roukoz H, Majhail NS. Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations in acute promyelocytic leukemia: a systematic review. Leuk Res. 2010;34:831\u20136.","journal-title":"Leuk Res"},{"key":"69_CR21","doi-asserted-by":"crossref","first-page":"42733","DOI":"10.18632\/oncotarget.5811","volume":"6","author":"YW Chang","year":"2015","unstructured":"Chang Y-W, Hsieh P-W, Chang Y-T, Lu M-H, Huang T-F, Chong K-Y, et al. Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasis. Oncotarget. 2015;6:42733\u201348.","journal-title":"Oncotarget"},{"key":"69_CR22","doi-asserted-by":"publisher","first-page":"426","DOI":"10.2337\/diabetes.48.2.426","volume":"48","author":"M Nakata","year":"1999","unstructured":"Nakata M, Yada T, Soejima N, Maruyama I. Leptin promotes aggregation of human platelets via the long form of its receptor. Diabetes. 1999;48:426\u20139.","journal-title":"Diabetes"},{"key":"69_CR23","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.1093\/emboj\/cdg342","volume":"22","author":"V Schacht","year":"2003","unstructured":"Schacht V, Ramirez MI, Hong Y-KK, Hirakawa S, Feng D, Harvey N, et al. T1alpha\/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J. 2003;22:3546\u201356.","journal-title":"EMBO J"},{"key":"69_CR24","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1182\/blood-2009-04-216069","volume":"115","author":"P Uhrin","year":"2010","unstructured":"Uhrin P, Zaujec J, Breuss JM, Olcaydu D, Chrenek P, Stockinger H, et al. Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation. Blood. 2010;115:3997\u20134005.","journal-title":"Blood"},{"key":"69_CR25","doi-asserted-by":"publisher","first-page":"25993","DOI":"10.1074\/jbc.M702327200","volume":"282","author":"K Suzuki-Inoue","year":"2007","unstructured":"Suzuki-Inoue K, Kato Y, Inoue O, Kaneko MK, Mishima K, Yatomi Y, et al. Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells. J Biol Chem. 2007;282:25993\u20136001.","journal-title":"J Biol Chem"},{"key":"69_CR26","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1182\/blood-2016-06-720714","volume":"129","author":"J Riedl","year":"2017","unstructured":"Riedl J, Preusser M, Mir Seyed Nazari P, Posch F, Panzer S, Marosi C, et al. Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism. Blood. 2017;129:1831\u20139.","journal-title":"Blood"},{"issue":"5B","key":"69_CR27","first-page":"2997","volume":"28","author":"M Raica","year":"2008","unstructured":"Raica M, Cimpean AM, Ribatti D. The role of podoplanin in tumor progression and metastasis. Anticancer Res. 2008;28(5B):2997\u20133006.","journal-title":"Anticancer Res"},{"key":"69_CR28","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.thromres.2012.11.024","volume":"131","author":"A Rashidi","year":"2013","unstructured":"Rashidi A, Silverberg ML, Conkling PR, Fisher SI. Thrombosis in acute promyelocytic leukemia. Thromb Res. 2013;131:281\u20139.","journal-title":"Thromb Res"},{"key":"69_CR29","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.thromres.2014.11.026","volume":"135","author":"M Mitrovic","year":"2015","unstructured":"Mitrovic M, Suvajdzic N, Elezovic I, Bogdanovic A, Djordjevic V, Miljic P, et al. Thrombotic events in acute promyelocytic leukemia. Thromb Res. 2015;135:588\u201393.","journal-title":"Thromb Res"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41375-018-0069-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-018-0069-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-018-0069-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:33:36Z","timestamp":1684618416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-018-0069-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,23]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["69"],"URL":"https:\/\/doi.org\/10.1038\/s41375-018-0069-1","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,23]]},"assertion":[{"value":"22 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}